Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
Abstract Background Currently, serum PSA is the most commonly used screening tool in clinical practice. However, PSA levels in the range of 4–10 ng/ml are considered the ‘grey zone’ of prostate cancer screening. Patients within this range need to be further evaluated using additional parameters such...
Saved in:
Main Authors: | Yuxuan Chen, Haisheng Yan, Yaoqin Xu, Kexin Chen, Runqin Yang, Jiali Yang, Ruian Zhu, Rui Lin, Jiang Wang, Jie Liu, Pingsheng Gao, Lei Pang, Lexin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-01-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-025-01760-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
by: Matteo Pacini, et al.
Published: (2025-02-01) -
Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups
by: Mohamed O. Andarawi, et al.
Published: (2025-02-01) -
Urology pathways for the primary care physician
by: J John
Published: (2024-04-01) -
Prostate cancer perspective: Africa versus the world
by: B Marais, et al.
Published: (2024-04-01) -
Insights into prostate cancer awareness and perceptions among men in Tshwane
by: L Nzombe, et al.
Published: (2024-06-01)